Abstract: |
Drug repositioning is a process that, by means of identifying new targets for a specific drug, changes its initial purpose. Analyzing biological interactions, i.e., relationships between drugs and their targets, or associations between cell lines and genes, is an effective approach for drug repositioning, and for predicting side effects of drugs in patients. Drug repositioning based on the analysis of scientific literature is growing at a quick pace, becoming a high-impact big data problem. Health big data can benefit from being analyzed using machine learning strategies for extracting and summarizing information, and automated processing will allow scaling up the analysis with a much broader set of data.
The main goal of this work is to develop a set of computational models to automatically identify, classify, and discover new biological interactions, namely new drug-disease interactions, as well as drug-cell line interactions. Machine learning and data mining techniques are used to identify interactions over a set of pharmacological and biological databases, and scientific literature. Data for these analyses will be obtained from scientific literature and open databases, such as ChEMBL, DrugBank, KEGG, PubMed, OMIM, etc. Once interactions are classified, we will introduce a prediction model to identify new possible effects of known drugs.
Preliminary work has shown promising results for characterizing cell lines and diseases, and for discovering new interactions between chemical compounds and cell lines, as well as between chemical compounds and diseases. |